Barclays Initiates Coverage On Humacyte with Equal-Weight Rating, Announces Price Target of $0.5
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Barclays analyst Christopher Pasquale initiates coverage on Humacyte (NASDAQ:HUMA) with a Equal-Weight rating and announces Price Target of $0.5.
Barclays analyst Christopher Pasquale initiates coverage on Humacyte (NASDAQ:HUMA) with a Equal-Weight rating and announces Price Target of $0.5.